CPD (carboxypeptidase D)

2007-02-01  

Identity

HGNC
LOCATION
17q11.2
LOCUSID
ALIAS
GP180
FUSION GENES

Other Information

Locus ID:

NCBI: 1362
MIM: 603102
HGNC: 2301
Ensembl: ENSG00000108582

Variants:

dbSNP: 1362
ClinVar: 1362
TCGA: ENSG00000108582
COSMIC: CPD

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000108582ENST00000225719O75976
ENSG00000108582ENST00000543464O75976
ENSG00000108582ENST00000579502J3QRJ9
ENSG00000108582ENST00000584050K7ELF0
ENSG00000108582ENST00000584221J3QQJ4

Expression (GTEx)

0
10
20
30
40
50
60

Pathways

PathwaySourceExternal ID
Vesicle-mediated transportREACTOMER-HSA-5653656
Membrane TraffickingREACTOMER-HSA-199991
trans-Golgi Network Vesicle BuddingREACTOMER-HSA-199992
Clathrin derived vesicle buddingREACTOMER-HSA-421837
Golgi Associated Vesicle BiogenesisREACTOMER-HSA-432722

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
283642162017Prolactin/androgen-inducible carboxypeptidase-D increases with nitrotyrosine and Ki67 for breast cancer progression in vivo, and upregulates progression markers VEGF-C and Runx2 in vitro.9
283642162017Prolactin/androgen-inducible carboxypeptidase-D increases with nitrotyrosine and Ki67 for breast cancer progression in vivo, and upregulates progression markers VEGF-C and Runx2 in vitro.9
274947422016microRNA-214 Governs Lung Cancer Growth and Metastasis by Targeting Carboxypeptidase-D.9
274947422016microRNA-214 Governs Lung Cancer Growth and Metastasis by Targeting Carboxypeptidase-D.9
244330402014Prolactin/Stat5 and androgen R1881 coactivate carboxypeptidase-D gene in breast cancer cells.3
246157302014Carboxypeptidase-D is elevated in prostate cancer and its anti-apoptotic activity is abolished by combined androgen and prolactin receptor targeting.7
252948782014Amyloid formation by human carboxypeptidase D transthyretin-like domain under physiological conditions.12
244330402014Prolactin/Stat5 and androgen R1881 coactivate carboxypeptidase-D gene in breast cancer cells.3
246157302014Carboxypeptidase-D is elevated in prostate cancer and its anti-apoptotic activity is abolished by combined androgen and prolactin receptor targeting.7
252948782014Amyloid formation by human carboxypeptidase D transthyretin-like domain under physiological conditions.12
235893952013SiRNA-targeted carboxypeptidase D inhibits hepatocellular carcinoma growth.2
235893952013SiRNA-targeted carboxypeptidase D inhibits hepatocellular carcinoma growth.2
216289992011Differential regulation and localization of carboxypeptidase D and carboxypeptidase E in human and mouse β-cells.4
216289992011Differential regulation and localization of carboxypeptidase D and carboxypeptidase E in human and mouse β-cells.4
185351092008Prolactin and estrogen up-regulate carboxypeptidase-d to promote nitric oxide production and survival of mcf-7 breast cancer cells.12

Citation

Dessen P

CPD (carboxypeptidase D)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/46417/img/css/lib/css/template-card.css